Medicxi put €40m into two Sosei spin off companies

The newly created companies Orexia Ltd and Inexia Ltd aim to develop orally or intranasally administered drug candidates to treat...

Small-molecule acts as broad-band influenza entry blocker

The small molecule, code-named JNJ4796, targets a part of viral hemagglutinin (HA), which is common to all influenza A group 1 viruses but not found...

Drug dissociates metastasis precursors in blood

In Cell, the team headed by Nicola Aceto from University Hospital Basel, Switzerland, reported that a screening of 2,486 FDA-approved...

EMA greenlights two orphan drugs and two biosimilars

Two of six new meds to be approved in Europe are biosimilar medicines and have been backed by the European Medicines Agency (EMA) this...

How salt triggers allergy

German researchers have found that or sodium chloride could be a promotor in allergic responses of the immune system. In Science Translational...

Anaveon bags CHF35m series A financing

Syncona Ltd led the financing round with an CHF28m investment acquiring a 47% stake in the Swiss immuno-oncology specialist, that got seed financing...

How stroma cells trigger tumour angiogenesis

In Science Signalling, a team of UK researchers headed by Sara Zanivan report they identified a factor secreted by tumour stromal cells...